Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights". Click on the premium insights link below to filter for just the premium content.



Signify Premium Insight: General Radiography and Fluoroscopy’s Changing Fortunes

Signify Premium Insights Subscription Required

1st September 2021 – In this Premium Insight, co-author of Signify Research’s General Radiography and Fluoroscopy report Bhvita Jani details some of her report’s findings.

Signify Premium Insight: Vendor Financials Roundup – The Health of the Imaging Sector Q2 2021

Signify Premium Insights Subscription Required

26th August 2021 – The narratives of 2021’s second quarter are captured in vendors’ financial results. This Premium Insight identifies some of the quarter’s key trends and assesses the performance of various medical imaging and imaging IT vendors.

Signify Premium Insight: Butterfly Network and Caption Health Partner to Encourage Ultrasound Adoption

Signify Premium Insights Subscription Required

24th August 2021 – Butterfly Network’s recently announced partnership with Caption Health has the potential to overcome one of the biggest barriers facing handheld ultrasound. But, as this Premium Insight explores, there could also be some downsides to the deal.

Signify Premium Insight: HIMSS 2021: Steps not Step Changes

Signify Premium Insights Subscription Required

19th August 2021 – For many, HIMSS 2021 will have been the first in-person event they attended in almost two years. This Premium Insight details several announcements made at the conference and explores what they could mean for the Imaging IT market.

Nihon Kohden’s Acquisition of AMP3D Further Highlights Interest of Analytics in the Clinical World

19th August 2021 – On the 27th of July 2021, the US subsidiary of Nihon Kohden (Nihon Kohden Digital Health Solutions, Inc.) announced that it was to acquire 100% of the shares of US-based Advanced Medical Predictive Devices, Diagnostics and Displays, Inc. (“AMP3D”)